Featured Posts
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager (PBM)…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power innovation,…
National Review
Telehealth Is Less Promising Than It First Seemed
A key issue facing Congress in its postelection, “lame duck” session is whether to extend regulatory flexibilities expiring at year end that make telehealth services more…
Search Posts
Op-Eds
Dangerous GM Gets Off Scot-Free
Conko and Miller Op-Ed in The Wall Street Journal Europe<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> …
Op-Eds
Cutting Regulation From the EPA: Gene-splicing Policy Should Be Excised
Miller Op-Ed in The Washington TImes Miller Op-Ed in The Washington Times A persistent criticism of the…
Op-Eds
Plants Are Not Pesticides
Miller Op-Ed in The National Post<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> A New U.S. EPA…
News Release
Public Interest Group Welcomes CDC StarLink Report
Washington, DC, June 14, 2001—The Competitive Enterprise Institute welcomes a report by the Centers for Disease Control that finds…
Op-Eds
The Perils Of Precaution
Miller and Conko Article Published In Policy Review<?xml:namespace prefix = o ns = “urn:schemas-microsoft-com:office:office” /> Environmental and public health activists have clashed with scholars…
News Release
CEI Comments Before FDA on Bioengineered Foods
COMMENTS OF THE COMMENTS OF THE COMPETITIVE ENTERPRISE INSTITUTE TO THE FOOD AND DRUG ADMINISTRATION REGARDING THE…